ECASS 3 supports use of tPA up to 4.5 hours after stroke

28 October 2009 | by Amy Corderoy Print this article Comments Share this article
Further analyses of data from the third European Cooperative Acute Stroke Study support the use of recombinant tissue plasminogen activator (tPA) to treat stroke up to 4.5 hours after symptom onset....

Want to read complete article? Please Sign in or Register.

Recent comments

Most viewed articles this week

Related sites